Eva Roblegg

Prof. Eva Roblegg

orcid

Research Focus & Metrics

Academic Career Length

18Years (2009-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 January 2012 in Toxicology
Verified
Journal Article
Open access
Eleonore FröhlichEleonore Fröhlich
Eleonore Fröhlich
EREva Roblegg
Eva Roblegg
Presently, many consumer products contain nano-sized materials (NMs) to improve material properties, product quality and ease of use. NMs in food additives and in cosmetic articles (e.g., tooth paste) may be taken up by the oral route. As adverse effects of environmental nanoparticles, like ultrafine particles, have been reported, consumers worry about potential risks when using products containing NMs. The review focuses on metal and metal oxide NMs as common additives in tooth paste and in food industry and exposure by the oral route. Testing of NMs for oral exposure is very complex because differences in the diet, in mucus secretion and composition, in pH, in gastrointestinal transit time and in gastrointestinal flora influence NM uptake. Acellular (mucus, saliva) and epithelial layer of the orogastrointestinal barrier are described. Expected exposure doses, interaction of the NMs with mucus and permeation through the epithelium as well as in vivo data are mentioned. The role of in vitro models for the study of parameters relevant for ingested NMs is discussed.

29 November 2013 in Cell Biology and Toxicology
Verified
Journal Article
Closed access
PDF file
BPBarbara Prietl
Barbara Prietl
CMC. Meindl
C. Meindl
EREva Roblegg
Eva Roblegg
TPT. R. Pieber
T. R. Pieber
GLG. Lanzer
G. Lanzer
Eleonore FröhlichEleonore Fröhlich
Eleonore Fröhlich

6 February 2014 in Molecular Pharmaceutics
Verified
Journal Article
Closed access
CSChrista Schimpel
Christa Schimpel
BTBirgit Teubl
Birgit Teubl
MAMarkus Absenger
Markus Absenger
CMClaudia Meindl
Claudia Meindl
Eleonore FröhlichEleonore Fröhlich
Eleonore Fröhlich
EREva Roblegg
Eva Roblegg

1 September 2019 in European Journal of Pharmaceutics and Biopharmaceutics
Verified
Journal Article
Closed access
EREva Roblegg
Eva Roblegg
ACAlanna Coughran
Alanna Coughran
DSDavud Sirjani
Davud Sirjani

1 December 2013 in Journal of Controlled Release
Verified
Journal Article
Open access
KGK. Gradauer
K. Gradauer
JBJ. Barthelmes
J. Barthelmes
CVC. Vonach
C. Vonach
GAGunter Almer
Gunter Almer
HMHarald Mangge
Harald Mangge
RPRuth Prassl
Ruth Prassl
The aim of the present study was the in vivo evaluation of thiomer-coated liposomes for an oral application of peptides. For this purpose, salmon calcitonin was chosen as a model drug and encapsulated within liposomes. Subsequently, the drug loaded liposomes were coated with either chitosan-thioglycolic acid (CS-TGA) or an S-protected version of the same polymer (CS-TGA-MNA), leading to an increase in the particle size of about 500 nm and an increase in the zeta potential from approximately -40 mV to a maximum value of about +44 mV, depending on the polymer. Coated liposomes were demonstrated to effectively penetrate the intestinal mucus layer where they came in close contact with the underlying epithelium. To investigate the permeation enhancing properties of the coated liposomes ex vivo, we monitored the transport of fluoresceinisothiocyanate-labeled salmon calcitonin (FITC-sCT) through rat small intestine. Liposomes coated with CS-TGA-MNA showed the highest effect, leading to a 3.8-fold increase in the uptake of FITC-sCT versus the buffer control. In vivo evaluation of the different formulations was carried out by the oral application of 40 μg of sCT per rat, either encapsulated within uncoated liposomes, CS-TGA-coated liposomes or CS-TGA-MNA-coated liposomes, or given as a solution serving as negative control. The blood calcium level was monitored over a time period of 24h. The highest reduction in the blood calcium level, to a minimum of 65% of the initial value after 6h, was achieved for CS-TGA-MNA-coated liposomes. Comparing the areas above curves (AAC) of the blood calcium levels, CS-TGA-MNA-coated liposomes led to an 8.2-fold increase compared to the free sCT solution if applied orally in the same concentration. According to these results, liposomes coated with S-protected thiomers have demonstrated to be highly valuable carriers for enhancing the oral bioavailability of salmon calcitonin.

1 February 2013 in Toxicology in Vitro
Verified
Journal Article
Open access
Eleonore FröhlichEleonore Fröhlich
Eleonore Fröhlich
GBGudrun Bonstingl
Gudrun Bonstingl
AHAnita Höfler
Anita Höfler
CMClaudia Meindl
Claudia Meindl
GLGerd Leitinger
Gerd Leitinger
EREva Roblegg
Eva Roblegg
Inhalation treatment with nanoparticle containing aerosols appears a promising new therapeutic option but new formulations have to be assessed for efficacy and toxicity. We evaluated the utility of a VITROCELL®6 PT-CF+PARI LC SPRINT® Baby Nebulizer (PARI BOY) system compared with a conventional MicroSprayer. A549 cells were cultured in the air-liquid interface, exposed to nanoparticle aerosols and characterized by measurement of transepithelial electrical resistance and staining for tight junction proteins. Deposition and distribution rates of polystyrene particles and of carbon nanotubes on the cells were assessed. In addition, cytotoxicity of aerosols containing polystyrene particles was compared with cytotoxicity of polystyrene particles in suspension tested in submersed cultures. Exposure by itself in both exposure systems did not damage the cells. Deposition rates of aerosolized polystyrene particles were about 700 times and that of carbon nanotubes about 4 times higher in the MicroSprayer than in the VITROCELL®6 PT-CF system. Cytotoxicity of amine-functionalized polystyrene nanoparticles was significantly higher when applied as an aerosol on cell cultured in air-liquid interface culture compared with nanoparticle suspensions tested in submersed culture. The higher cytotoxicity of aerosolized nanoparticles underscores the importance of relevant exposure systems.